Back to Journals » Drug Design, Development and Therapy » Volume 12

CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia

Total article views   HTML views PDF downloads Totals
39,855 Dovepress* 20,031+ 2,566 22,597
PubMed Central* 19,824 3,077 22,901
Totals 39,855 5,643 45,498
*Since 12 November 2018
Total mentioned Facebook Delicious Reddit Twitter Others
11 1 0 0 1 9

View citations on PubMed Central and Google Scholar